[
  {
    "ts": null,
    "headline": "Big Tech and Pharma Earnings: What to Watch This Week",
    "summary": "Earnings season marches on this week. Two more Magnificent Seven tech companies—Alphabet and Amazon—will report, following on the heels of disappointing results from Microsoft that helped send software stocks tumbling last week.",
    "url": "https://finnhub.io/api/news?id=c28a9c55f89b6e4ee3a2cc078c7c5c981f88e6e147d5c4b3cf134c4c4ad2d164",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770073343,
      "headline": "Big Tech and Pharma Earnings: What to Watch This Week",
      "id": 138337200,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Earnings season marches on this week. Two more Magnificent Seven tech companies—Alphabet and Amazon—will report, following on the heels of disappointing results from Microsoft that helped send software stocks tumbling last week.",
      "url": "https://finnhub.io/api/news?id=c28a9c55f89b6e4ee3a2cc078c7c5c981f88e6e147d5c4b3cf134c4c4ad2d164"
    }
  },
  {
    "ts": null,
    "headline": "Here's Why You Should Add Inogen Stock to Your Portfolio Now",
    "summary": "INGN looks poised as Q3 revenue rises 4%, POC demand grows and valuation is low, despite seasonal softness.",
    "url": "https://finnhub.io/api/news?id=eb73a36d38ebe7c31171cf33930e725177cbb9454a2fd48d0192e77fa58ee86d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770043860,
      "headline": "Here's Why You Should Add Inogen Stock to Your Portfolio Now",
      "id": 138333808,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "INGN looks poised as Q3 revenue rises 4%, POC demand grows and valuation is low, despite seasonal softness.",
      "url": "https://finnhub.io/api/news?id=eb73a36d38ebe7c31171cf33930e725177cbb9454a2fd48d0192e77fa58ee86d"
    }
  },
  {
    "ts": null,
    "headline": "Revvity Stock Up as Q4 Earnings Beat, Revenues In Line With Estimates",
    "summary": "RVTY stock climbs after Q4 adjusted EPS of $1.70 top estimates with revenue improving 5.9% to $772.1 million.",
    "url": "https://finnhub.io/api/news?id=32eecebe9835f5ee73527b7772e1f39d3b73175915707ea1eedf56592a34e895",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770043740,
      "headline": "Revvity Stock Up as Q4 Earnings Beat, Revenues In Line With Estimates",
      "id": 138333809,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "RVTY stock climbs after Q4 adjusted EPS of $1.70 top estimates with revenue improving 5.9% to $772.1 million.",
      "url": "https://finnhub.io/api/news?id=32eecebe9835f5ee73527b7772e1f39d3b73175915707ea1eedf56592a34e895"
    }
  },
  {
    "ts": null,
    "headline": "4 Medical Product Stocks to Watch From a Challenging Industry",
    "summary": "The Zacks Medical products industry faces macro headwinds, keeping growth under pressure in 2026, but steady demand may continue. BSX, RMD, PAHC and BLFS reflect the favorable fundamentals.",
    "url": "https://finnhub.io/api/news?id=22639bcd2b561a2b5dc2239d4a044ef35777a5c3c313ac136aefaf9ba530598f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770041280,
      "headline": "4 Medical Product Stocks to Watch From a Challenging Industry",
      "id": 138332710,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "The Zacks Medical products industry faces macro headwinds, keeping growth under pressure in 2026, but steady demand may continue. BSX, RMD, PAHC and BLFS reflect the favorable fundamentals.",
      "url": "https://finnhub.io/api/news?id=22639bcd2b561a2b5dc2239d4a044ef35777a5c3c313ac136aefaf9ba530598f"
    }
  },
  {
    "ts": null,
    "headline": "Jobs Report, Big Tech and Pharma Earnings: What to Watch This Week",
    "summary": "Earnings season marches on. Two more Magnificent Seven tech companies—Alphabet and Amazon—will report this week, following on the heels of disappointing results from Microsoft that helped send software stocks tumbling.",
    "url": "https://finnhub.io/api/news?id=a3c960b1f15989f8e98d3cbced37cd59212105d1a1e567048fec0391991b33f8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770016421,
      "headline": "Jobs Report, Big Tech and Pharma Earnings: What to Watch This Week",
      "id": 138329655,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Earnings season marches on. Two more Magnificent Seven tech companies—Alphabet and Amazon—will report this week, following on the heels of disappointing results from Microsoft that helped send software stocks tumbling.",
      "url": "https://finnhub.io/api/news?id=a3c960b1f15989f8e98d3cbced37cd59212105d1a1e567048fec0391991b33f8"
    }
  },
  {
    "ts": null,
    "headline": "How Surging Heart-Device Demand And Margin Gains At Boston Scientific (BSX) Has Changed Its Investment Story",
    "summary": "Boston Scientific recently reported past third-quarter 2025 results that surpassed expectations on both adjusted earnings per share and revenue, while raising its full-year 2025 EPS guidance and issuing a stronger-than-expected fourth-quarter outlook driven by demand for heart devices such as Watchman and Farapulse. An interesting angle for investors is how this strong electrophysiology growth, together with improving operating margins despite tariff pressures, is reshaping Boston...",
    "url": "https://finnhub.io/api/news?id=5e1d99f45d9b7baaefaefd6e4eee0fe3178b066fd63e1d73a00db06ff0fc0f42",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770016146,
      "headline": "How Surging Heart-Device Demand And Margin Gains At Boston Scientific (BSX) Has Changed Its Investment Story",
      "id": 138329702,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific recently reported past third-quarter 2025 results that surpassed expectations on both adjusted earnings per share and revenue, while raising its full-year 2025 EPS guidance and issuing a stronger-than-expected fourth-quarter outlook driven by demand for heart devices such as Watchman and Farapulse. An interesting angle for investors is how this strong electrophysiology growth, together with improving operating margins despite tariff pressures, is reshaping Boston...",
      "url": "https://finnhub.io/api/news?id=5e1d99f45d9b7baaefaefd6e4eee0fe3178b066fd63e1d73a00db06ff0fc0f42"
    }
  },
  {
    "ts": null,
    "headline": "Deal fever returns: 2026 looks hot for M&A",
    "summary": "It’s looking like 2026 is going to be a big year for mergers and acquisitions.We’re just one month into the new year and already we’ve seen major deals, including Netflix’s (NFLX) announced $82.7 billion acquisition of Warner Bros. Discovery (WBD), whose terms were updated in January, Global ...",
    "url": "https://finnhub.io/api/news?id=88d5a49f4f47f132f0d3be827fe2e6660df883804e7ec47f138392af086a169e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770005580,
      "headline": "Deal fever returns: 2026 looks hot for M&A",
      "id": 138329253,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "It’s looking like 2026 is going to be a big year for mergers and acquisitions.We’re just one month into the new year and already we’ve seen major deals, including Netflix’s (NFLX) announced $82.7 billion acquisition of Warner Bros. Discovery (WBD), whose terms were updated in January, Global ...",
      "url": "https://finnhub.io/api/news?id=88d5a49f4f47f132f0d3be827fe2e6660df883804e7ec47f138392af086a169e"
    }
  }
]